A. Ramachandaram, “REAL-WORLD EVIDENCE FOR THE USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AT A MALAYSIAN TERTIARY CARE CENTRE”, J ASEAN Fed Endocr Soc, vol. 38, no. S3, p. 52, Nov. 2023.